Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.99961559 |
2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.50963721 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.23465001 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.23465001 |
5 | negative T cell selection (GO:0043383) | 6.03656164 |
6 | negative thymic T cell selection (GO:0045060) | 5.99892936 |
7 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.55002627 |
8 | positive thymic T cell selection (GO:0045059) | 5.48777101 |
9 | response to interleukin-15 (GO:0070672) | 5.38407701 |
10 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.37002698 |
11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.27241043 |
12 | regulation of gamma-delta T cell activation (GO:0046643) | 5.08597366 |
13 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.00687229 |
14 | thymic T cell selection (GO:0045061) | 4.93186464 |
15 | positive T cell selection (GO:0043368) | 4.90224226 |
16 | cellular response to interleukin-15 (GO:0071350) | 4.86609438 |
17 | T cell selection (GO:0045058) | 4.74242398 |
18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.64333563 |
19 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.56801474 |
20 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.51130386 |
21 | B cell receptor signaling pathway (GO:0050853) | 4.47232292 |
22 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.37109411 |
23 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.33426785 |
24 | tolerance induction (GO:0002507) | 4.31078151 |
25 | positive regulation of interleukin-2 production (GO:0032743) | 4.22273589 |
26 | T cell migration (GO:0072678) | 4.17937830 |
27 | regulation of T cell tolerance induction (GO:0002664) | 4.17050299 |
28 | interferon-gamma production (GO:0032609) | 4.12591114 |
29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.06180646 |
30 | negative regulation of cell killing (GO:0031342) | 4.06180646 |
31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.01211634 |
32 | leukocyte aggregation (GO:0070486) | 3.99274528 |
33 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.96644308 |
34 | regulation of B cell differentiation (GO:0045577) | 3.93293098 |
35 | T cell costimulation (GO:0031295) | 3.93242275 |
36 | DNA deamination (GO:0045006) | 3.88149220 |
37 | lymphocyte costimulation (GO:0031294) | 3.87126908 |
38 | NIK/NF-kappaB signaling (GO:0038061) | 3.80316884 |
39 | positive regulation of humoral immune response (GO:0002922) | 3.78690932 |
40 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.75652606 |
41 | regulation of regulatory T cell differentiation (GO:0045589) | 3.74360702 |
42 | positive regulation of B cell differentiation (GO:0045579) | 3.69263366 |
43 | positive regulation of defense response to virus by host (GO:0002230) | 3.63505641 |
44 | positive regulation of isotype switching (GO:0045830) | 3.61369138 |
45 | T cell receptor signaling pathway (GO:0050852) | 3.56531421 |
46 | activated T cell proliferation (GO:0050798) | 3.52854731 |
47 | mature B cell differentiation (GO:0002335) | 3.52782699 |
48 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.51637311 |
49 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.50150821 |
50 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.45708511 |
51 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.45342775 |
52 | regulation of B cell proliferation (GO:0030888) | 3.45109535 |
53 | response to type I interferon (GO:0034340) | 3.43318775 |
54 | germinal center formation (GO:0002467) | 3.41812448 |
55 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.40567836 |
56 | type I interferon signaling pathway (GO:0060337) | 3.37565301 |
57 | cellular response to type I interferon (GO:0071357) | 3.37565301 |
58 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.37182474 |
59 | behavioral response to nicotine (GO:0035095) | 3.36384052 |
60 | negative regulation of T cell mediated immunity (GO:0002710) | 3.32462577 |
61 | regulation of interleukin-2 production (GO:0032663) | 3.29775758 |
62 | positive regulation of B cell proliferation (GO:0030890) | 3.27096475 |
63 | defense response to protozoan (GO:0042832) | 3.26467772 |
64 | lymphocyte homeostasis (GO:0002260) | 3.24950960 |
65 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.24504636 |
66 | positive regulation of immunoglobulin production (GO:0002639) | 3.22540255 |
67 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.22234116 |
68 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.22234116 |
69 | B cell proliferation (GO:0042100) | 3.22200865 |
70 | myeloid dendritic cell activation (GO:0001773) | 3.21358236 |
71 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.21343912 |
72 | positive regulation of B cell mediated immunity (GO:0002714) | 3.21343912 |
73 | positive regulation of B cell activation (GO:0050871) | 3.21044320 |
74 | T cell homeostasis (GO:0043029) | 3.19111389 |
75 | positive regulation of DNA recombination (GO:0045911) | 3.18855355 |
76 | B cell homeostasis (GO:0001782) | 3.18545572 |
77 | mast cell activation (GO:0045576) | 3.15981919 |
78 | response to protozoan (GO:0001562) | 3.15092248 |
79 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.14673178 |
80 | L-fucose catabolic process (GO:0042355) | 3.14562539 |
81 | fucose catabolic process (GO:0019317) | 3.14562539 |
82 | L-fucose metabolic process (GO:0042354) | 3.14562539 |
83 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.13641856 |
84 | positive regulation of granulocyte differentiation (GO:0030854) | 3.10855658 |
85 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.10183285 |
86 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.10183285 |
87 | negative regulation of B cell proliferation (GO:0030889) | 3.10177388 |
88 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.09347959 |
89 | myeloid dendritic cell differentiation (GO:0043011) | 3.08390419 |
90 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08180726 |
91 | modulation by symbiont of host immune response (GO:0052553) | 3.08067900 |
92 | positive regulation by symbiont of host defense response (GO:0052509) | 3.08067900 |
93 | modulation by symbiont of host defense response (GO:0052031) | 3.08067900 |
94 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.08067900 |
95 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.08067900 |
96 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.08067900 |
97 | regulation of isotype switching (GO:0045191) | 3.06569260 |
98 | negative regulation of interleukin-12 production (GO:0032695) | 3.05228990 |
99 | positive regulation of antigen processing and presentation (GO:0002579) | 3.04955116 |
100 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.03554141 |
101 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.02215613 |
102 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.00297180 |
103 | cytidine metabolic process (GO:0046087) | 2.99959815 |
104 | cytidine catabolic process (GO:0006216) | 2.99959815 |
105 | cytidine deamination (GO:0009972) | 2.99959815 |
106 | regulation of response to interferon-gamma (GO:0060330) | 2.99568279 |
107 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.98850533 |
108 | regulation of B cell activation (GO:0050864) | 2.98066778 |
109 | mast cell degranulation (GO:0043303) | 2.98021581 |
110 | mast cell activation involved in immune response (GO:0002279) | 2.98021581 |
111 | regulation of B cell mediated immunity (GO:0002712) | 2.97711441 |
112 | regulation of immunoglobulin production (GO:0002637) | 2.95805579 |
113 | regulation of tolerance induction (GO:0002643) | 2.94547626 |
114 | T cell proliferation (GO:0042098) | 2.94304050 |
115 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.94273549 |
116 | regulation of alpha-beta T cell activation (GO:0046634) | 2.94251923 |
117 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.92583627 |
118 | alpha-beta T cell differentiation (GO:0046632) | 2.90733261 |
119 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.83102438 |
120 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.81834937 |
121 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.81706843 |
122 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.78583274 |
123 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.73934759 |
124 | Peyers patch development (GO:0048541) | 2.73875318 |
125 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.73875318 |
126 | regulation of defense response to virus by host (GO:0050691) | 2.73364851 |
127 | regulation of cell killing (GO:0031341) | 2.71321869 |
128 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.69890253 |
129 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.69693381 |
130 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.68763392 |
131 | positive regulation of cell killing (GO:0031343) | 2.68563718 |
132 | negative regulation of telomere maintenance (GO:0032205) | 2.67769999 |
133 | cellular response to interferon-beta (GO:0035458) | 2.67503276 |
134 | alpha-beta T cell activation (GO:0046631) | 2.67181245 |
135 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.59859828 |
136 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.59661128 |
137 | negative regulation of mast cell activation (GO:0033004) | 2.59659458 |
138 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.59409203 |
139 | response to pheromone (GO:0019236) | 2.56538022 |
140 | indolalkylamine metabolic process (GO:0006586) | 2.56253550 |
141 | regulation of antigen processing and presentation (GO:0002577) | 2.55831791 |
142 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.52170957 |
143 | immunoglobulin mediated immune response (GO:0016064) | 2.52011977 |
144 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.48373377 |
145 | negative regulation of adaptive immune response (GO:0002820) | 2.47527207 |
146 | cellular response to exogenous dsRNA (GO:0071360) | 2.46987944 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.55106098 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.88970016 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.41758910 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.68444434 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.05628771 |
6 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.03328070 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.96177672 |
8 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.52704783 |
9 | MYC_22102868_ChIP-Seq_BL_Human | 3.44851828 |
10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.33700060 |
11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.31278603 |
12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.21352088 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13180115 |
14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.10715474 |
15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.08216323 |
16 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.07172903 |
17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.98543271 |
18 | * MYB_26560356_Chip-Seq_TH2_Human | 2.84681835 |
19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.64344016 |
20 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61856990 |
21 | * MAF_26560356_Chip-Seq_TH1_Human | 2.58017341 |
22 | * MYB_26560356_Chip-Seq_TH1_Human | 2.57166191 |
23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.50009494 |
24 | VDR_22108803_ChIP-Seq_LS180_Human | 2.44417381 |
25 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43594216 |
26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.35230987 |
27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.26711621 |
28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.25168257 |
29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.10753153 |
30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.04331203 |
31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.04229100 |
32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.03216836 |
33 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.02870315 |
34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.02330855 |
35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.97936325 |
36 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.87293720 |
37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.83840966 |
38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83134628 |
39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.83117298 |
40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.82750610 |
41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77593881 |
42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77084307 |
43 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.76366346 |
44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75808904 |
45 | * MAF_26560356_Chip-Seq_TH2_Human | 1.72978089 |
46 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.72241919 |
47 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.69642901 |
48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.69529960 |
49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.67987323 |
50 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.60955240 |
51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.60659596 |
52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.60266333 |
53 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.57607081 |
54 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55872211 |
55 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.54729354 |
56 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.54163058 |
57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.53940356 |
58 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.53056185 |
59 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.51463782 |
60 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.51409272 |
61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50254535 |
62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46431029 |
63 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.44674787 |
64 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.43444040 |
65 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.41628151 |
66 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.36244803 |
67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35880675 |
68 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.31002412 |
69 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28394957 |
70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.28179356 |
71 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27816870 |
72 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.27563127 |
73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.27349182 |
74 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.26582458 |
75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26502001 |
76 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26056847 |
77 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.25941850 |
78 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.21636383 |
79 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.19802891 |
80 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18873739 |
81 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.18759062 |
82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18738371 |
83 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.17764015 |
84 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.17335604 |
85 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.16910560 |
86 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.16602615 |
87 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16602615 |
88 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16499691 |
89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16006333 |
90 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.15881464 |
91 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.15800518 |
92 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15513208 |
93 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13941905 |
94 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.12499361 |
95 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.12499361 |
96 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.11211885 |
97 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.10834250 |
98 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.09853610 |
99 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.09820510 |
100 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.09742132 |
101 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08744670 |
102 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.07650747 |
103 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.07257934 |
104 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06576698 |
105 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.06568938 |
106 | FUS_26573619_Chip-Seq_HEK293_Human | 1.06225450 |
107 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.04809301 |
108 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.03235137 |
109 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02912091 |
110 | P300_19829295_ChIP-Seq_ESCs_Human | 1.02552924 |
111 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01904656 |
112 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01384207 |
113 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00868544 |
114 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00769410 |
115 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00360542 |
116 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.00070732 |
117 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.98176910 |
118 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.97990914 |
119 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97737960 |
120 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.97721449 |
121 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97313776 |
122 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96082979 |
123 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.95807920 |
124 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95633442 |
125 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95617552 |
126 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.94964575 |
127 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93928217 |
128 | NCOR_22424771_ChIP-Seq_293T_Human | 0.93810689 |
129 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.93770104 |
130 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.93536924 |
131 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93321651 |
132 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.92066572 |
133 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.92066572 |
134 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.92022313 |
135 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91615279 |
136 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.91289143 |
137 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.91289143 |
138 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.91278985 |
139 | GATA1_22025678_ChIP-Seq_K562_Human | 0.89376911 |
140 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.88368426 |
141 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.87552211 |
142 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85938299 |
143 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85329971 |
144 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84951171 |
145 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.83549932 |
146 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80813990 |
147 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.79142908 |
148 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78651578 |
149 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78350613 |
150 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75992299 |
151 | GATA3_26560356_Chip-Seq_TH1_Human | 0.73787965 |
152 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.71587281 |
153 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.69954113 |
154 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.69624911 |
155 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69215325 |
156 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.68092010 |
157 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.66851002 |
158 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.66067216 |
159 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.65579713 |
160 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65323622 |
161 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.65091875 |
162 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.63625757 |
163 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.63006802 |
164 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.62678325 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.74590639 |
2 | MP0001790_abnormal_immune_system | 4.06544782 |
3 | MP0005387_immune_system_phenotype | 4.06544782 |
4 | MP0001800_abnormal_humoral_immune | 3.95107810 |
5 | MP0003763_abnormal_thymus_physiology | 3.81889953 |
6 | MP0005671_abnormal_response_to | 3.80103868 |
7 | MP0000685_abnormal_immune_system | 3.61127464 |
8 | MP0005000_abnormal_immune_tolerance | 3.21486736 |
9 | MP0002452_abnormal_antigen_presenting | 3.17978967 |
10 | MP0003436_decreased_susceptibility_to | 3.07701558 |
11 | MP0002723_abnormal_immune_serum | 3.02306209 |
12 | MP0002420_abnormal_adaptive_immunity | 2.90247876 |
13 | MP0001819_abnormal_immune_cell | 2.85785537 |
14 | MP0009785_altered_susceptibility_to | 2.73447030 |
15 | MP0002398_abnormal_bone_marrow | 2.69537100 |
16 | MP0005025_abnormal_response_to | 2.52823199 |
17 | MP0003303_peritoneal_inflammation | 2.45291982 |
18 | MP0000716_abnormal_immune_system | 2.44936480 |
19 | MP0001873_stomach_inflammation | 2.43635942 |
20 | MP0002148_abnormal_hypersensitivity_rea | 2.37975952 |
21 | MP0002396_abnormal_hematopoietic_system | 2.35606651 |
22 | MP0002405_respiratory_system_inflammati | 2.32296854 |
23 | MP0000689_abnormal_spleen_morphology | 2.30574814 |
24 | MP0002166_altered_tumor_susceptibility | 2.27808538 |
25 | MP0009333_abnormal_splenocyte_physiolog | 2.27649208 |
26 | MP0002419_abnormal_innate_immunity | 2.21728137 |
27 | MP0010155_abnormal_intestine_physiology | 2.17240017 |
28 | MP0001986_abnormal_taste_sensitivity | 2.16134421 |
29 | MP0003300_gastrointestinal_ulcer | 2.14326733 |
30 | MP0002722_abnormal_immune_system | 2.09798814 |
31 | MP0003866_abnormal_defecation | 2.08865838 |
32 | MP0006082_CNS_inflammation | 2.04541252 |
33 | MP0002429_abnormal_blood_cell | 2.00198245 |
34 | MP0004510_myositis | 1.99006168 |
35 | MP0000703_abnormal_thymus_morphology | 1.98731834 |
36 | MP0002006_tumorigenesis | 1.91054503 |
37 | MP0008877_abnormal_DNA_methylation | 1.90742109 |
38 | MP0002933_joint_inflammation | 1.88834610 |
39 | MP0001845_abnormal_inflammatory_respons | 1.81850188 |
40 | MP0005310_abnormal_salivary_gland | 1.78123744 |
41 | MP0001853_heart_inflammation | 1.74487067 |
42 | MP0004947_skin_inflammation | 1.70870768 |
43 | MP0005464_abnormal_platelet_physiology | 1.59607467 |
44 | MP0003724_increased_susceptibility_to | 1.57477393 |
45 | MP0005645_abnormal_hypothalamus_physiol | 1.46950917 |
46 | MP0003195_calcinosis | 1.45379671 |
47 | MP0008872_abnormal_physiological_respon | 1.45317074 |
48 | MP0004808_abnormal_hematopoietic_stem | 1.43469611 |
49 | MP0002102_abnormal_ear_morphology | 1.43419547 |
50 | MP0008057_abnormal_DNA_replication | 1.39792946 |
51 | MP0004142_abnormal_muscle_tone | 1.33645661 |
52 | MP0000372_irregular_coat_pigmentation | 1.31868657 |
53 | MP0008469_abnormal_protein_level | 1.24955123 |
54 | MP0001533_abnormal_skeleton_physiology | 1.22943801 |
55 | MP0005551_abnormal_eye_electrophysiolog | 1.22124818 |
56 | MP0003646_muscle_fatigue | 1.21450526 |
57 | MP0000465_gastrointestinal_hemorrhage | 1.17310205 |
58 | MP0001501_abnormal_sleep_pattern | 1.14962333 |
59 | MP0000490_abnormal_crypts_of | 1.14207503 |
60 | MP0002138_abnormal_hepatobiliary_system | 1.10214791 |
61 | MP0005379_endocrine/exocrine_gland_phen | 1.05690244 |
62 | MP0003448_altered_tumor_morphology | 1.05271337 |
63 | MP0009764_decreased_sensitivity_to | 1.05009403 |
64 | MP0000569_abnormal_digit_pigmentation | 1.04047054 |
65 | MP0001968_abnormal_touch/_nociception | 1.03027727 |
66 | MP0000858_altered_metastatic_potential | 1.01650515 |
67 | MP0004742_abnormal_vestibular_system | 1.01185306 |
68 | MP0002876_abnormal_thyroid_physiology | 0.97345410 |
69 | MP0001545_abnormal_hematopoietic_system | 0.95941998 |
70 | MP0005397_hematopoietic_system_phenotyp | 0.95941998 |
71 | MP0002638_abnormal_pupillary_reflex | 0.95358741 |
72 | MP0002019_abnormal_tumor_incidence | 0.93982821 |
73 | MP0009745_abnormal_behavioral_response | 0.91313383 |
74 | MP0003183_abnormal_peptide_metabolism | 0.88503559 |
75 | MP0005167_abnormal_blood-brain_barrier | 0.87018886 |
76 | MP0005451_abnormal_body_composition | 0.84187759 |
77 | MP0005076_abnormal_cell_differentiation | 0.84156737 |
78 | MP0010307_abnormal_tumor_latency | 0.83202305 |
79 | MP0005174_abnormal_tail_pigmentation | 0.82996437 |
80 | MP0005084_abnormal_gallbladder_morpholo | 0.82620873 |
81 | MP0002998_abnormal_bone_remodeling | 0.81762577 |
82 | MP0004381_abnormal_hair_follicle | 0.80633403 |
83 | MP0004043_abnormal_pH_regulation | 0.80579561 |
84 | MP0002277_abnormal_respiratory_mucosa | 0.79873018 |
85 | MP0001919_abnormal_reproductive_system | 0.79692957 |
86 | MP0001485_abnormal_pinna_reflex | 0.78630908 |
87 | MP0010094_abnormal_chromosome_stability | 0.78620383 |
88 | MP0008875_abnormal_xenobiotic_pharmacok | 0.76958276 |
89 | MP0003252_abnormal_bile_duct | 0.76801940 |
90 | MP0003077_abnormal_cell_cycle | 0.76086813 |
91 | MP0008995_early_reproductive_senescence | 0.75272932 |
92 | MP0000427_abnormal_hair_cycle | 0.75220503 |
93 | MP0003045_fibrosis | 0.74386739 |
94 | MP0010352_gastrointestinal_tract_polyps | 0.72407705 |
95 | MP0001663_abnormal_digestive_system | 0.71769255 |
96 | MP0005253_abnormal_eye_physiology | 0.71544668 |
97 | MP0002095_abnormal_skin_pigmentation | 0.71200936 |
98 | MP0000015_abnormal_ear_pigmentation | 0.70368475 |
99 | MP0005075_abnormal_melanosome_morpholog | 0.70100548 |
100 | MP0003136_yellow_coat_color | 0.70024292 |
101 | MP0003172_abnormal_lysosome_physiology | 0.69970160 |
102 | MP0002254_reproductive_system_inflammat | 0.69921136 |
103 | MP0009278_abnormal_bone_marrow | 0.69095430 |
104 | MP0002653_abnormal_ependyma_morphology | 0.68663553 |
105 | MP0003787_abnormal_imprinting | 0.68052189 |
106 | MP0009046_muscle_twitch | 0.67826604 |
107 | MP0003693_abnormal_embryo_hatching | 0.67804407 |
108 | MP0004885_abnormal_endolymph | 0.67773804 |
109 | MP0003011_delayed_dark_adaptation | 0.67635908 |
110 | MP0002009_preneoplasia | 0.67599012 |
111 | MP0002837_dystrophic_cardiac_calcinosis | 0.66201331 |
112 | MP0006072_abnormal_retinal_apoptosis | 0.65723073 |
113 | MP0008007_abnormal_cellular_replicative | 0.64863995 |
114 | MP0005448_abnormal_energy_balance | 0.64199232 |
115 | MP0002136_abnormal_kidney_physiology | 0.63973645 |
116 | MP0005381_digestive/alimentary_phenotyp | 0.63143567 |
117 | MP0002735_abnormal_chemical_nociception | 0.63055704 |
118 | MP0003111_abnormal_nucleus_morphology | 0.61972608 |
119 | MP0002132_abnormal_respiratory_system | 0.61587042 |
120 | MP0001851_eye_inflammation | 0.61428952 |
121 | MP0009763_increased_sensitivity_to | 0.60201611 |
122 | MP0005166_decreased_susceptibility_to | 0.58671508 |
123 | MP0008058_abnormal_DNA_repair | 0.56725155 |
124 | MP0009765_abnormal_xenobiotic_induced | 0.55503764 |
125 | MP0000609_abnormal_liver_physiology | 0.55404561 |
126 | MP0002163_abnormal_gland_morphology | 0.52418890 |
127 | MP0008961_abnormal_basal_metabolism | 0.51760471 |
128 | MP0003795_abnormal_bone_structure | 0.50022414 |
129 | MP0001881_abnormal_mammary_gland | 0.49168189 |
130 | MP0003091_abnormal_cell_migration | 0.48677592 |
131 | MP0000313_abnormal_cell_death | 0.47897924 |
132 | MP0002928_abnormal_bile_duct | 0.46927259 |
133 | MP0001191_abnormal_skin_condition | 0.46673507 |
134 | MP0003453_abnormal_keratinocyte_physiol | 0.46416308 |
135 | MP0001348_abnormal_lacrimal_gland | 0.46053187 |
136 | MP0004782_abnormal_surfactant_physiolog | 0.45476547 |
137 | MP0000371_diluted_coat_color | 0.45413517 |
138 | MP0005390_skeleton_phenotype | 0.44384279 |
139 | MP0000249_abnormal_blood_vessel | 0.44205327 |
140 | MP0002693_abnormal_pancreas_physiology | 0.42817240 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Agammaglobulinemia (HP:0004432) | 5.26953703 |
2 | Recurrent bronchitis (HP:0002837) | 5.10565267 |
3 | Recurrent viral infections (HP:0004429) | 4.92740231 |
4 | Recurrent fungal infections (HP:0002841) | 4.88029869 |
5 | Chronic otitis media (HP:0000389) | 4.73499146 |
6 | Panhypogammaglobulinemia (HP:0003139) | 4.71545148 |
7 | T lymphocytopenia (HP:0005403) | 4.62744649 |
8 | Abnormality of T cell number (HP:0011839) | 4.56678728 |
9 | Eczematoid dermatitis (HP:0000976) | 4.53069536 |
10 | IgM deficiency (HP:0002850) | 4.51280988 |
11 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.47836929 |
12 | Recurrent cutaneous fungal infections (HP:0011370) | 4.47836929 |
13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.45925673 |
14 | Inflammation of the large intestine (HP:0002037) | 4.19497136 |
15 | Chronic diarrhea (HP:0002028) | 4.16655933 |
16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.13789123 |
17 | Recurrent sinusitis (HP:0011108) | 4.11181600 |
18 | Gastrointestinal stroma tumor (HP:0100723) | 4.08459956 |
19 | Meningitis (HP:0001287) | 4.03513936 |
20 | Myositis (HP:0100614) | 4.01028873 |
21 | Gastrointestinal inflammation (HP:0004386) | 3.98712400 |
22 | Vasculitis (HP:0002633) | 3.92903996 |
23 | Abnormality of T cells (HP:0002843) | 3.92848168 |
24 | Recurrent abscess formation (HP:0002722) | 3.89000069 |
25 | IgA deficiency (HP:0002720) | 3.82942856 |
26 | Abnormality of B cell number (HP:0010975) | 3.74636414 |
27 | B lymphocytopenia (HP:0010976) | 3.74636414 |
28 | Optic neuritis (HP:0100653) | 3.73457527 |
29 | Retrobulbar optic neuritis (HP:0100654) | 3.73457527 |
30 | Lymphopenia (HP:0001888) | 3.72152100 |
31 | Congenital stationary night blindness (HP:0007642) | 3.69792440 |
32 | Chronic sinusitis (HP:0011109) | 3.65931760 |
33 | Stomatitis (HP:0010280) | 3.63666432 |
34 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.58702960 |
35 | Colitis (HP:0002583) | 3.57819949 |
36 | IgG deficiency (HP:0004315) | 3.55479395 |
37 | Nasal polyposis (HP:0100582) | 3.54906823 |
38 | Pancreatic cysts (HP:0001737) | 3.54066583 |
39 | Cellulitis (HP:0100658) | 3.50723210 |
40 | Mediastinal lymphadenopathy (HP:0100721) | 3.49554947 |
41 | Abnormality of the fingertips (HP:0001211) | 3.42621288 |
42 | Recurrent bacterial skin infections (HP:0005406) | 3.41737606 |
43 | Severe combined immunodeficiency (HP:0004430) | 3.28385030 |
44 | Recurrent skin infections (HP:0001581) | 3.27186174 |
45 | Orchitis (HP:0100796) | 3.26946070 |
46 | Abnormality of T cell physiology (HP:0011840) | 3.26089472 |
47 | Autoimmune thrombocytopenia (HP:0001973) | 3.23036570 |
48 | Pulmonary infiltrates (HP:0002113) | 3.21927977 |
49 | Pustule (HP:0200039) | 3.17685688 |
50 | Combined immunodeficiency (HP:0005387) | 3.13470270 |
51 | Emphysema (HP:0002097) | 3.12763374 |
52 | Verrucae (HP:0200043) | 3.09339478 |
53 | Papilloma (HP:0012740) | 3.09339478 |
54 | Obstructive lung disease (HP:0006536) | 3.04811150 |
55 | Chronic obstructive pulmonary disease (HP:0006510) | 3.04811150 |
56 | Recurrent pneumonia (HP:0006532) | 3.01493627 |
57 | Molar tooth sign on MRI (HP:0002419) | 2.96842990 |
58 | Abnormality of midbrain morphology (HP:0002418) | 2.96842990 |
59 | Encephalitis (HP:0002383) | 2.91612124 |
60 | Abnormality of the renal cortex (HP:0011035) | 2.86486030 |
61 | Eosinophilia (HP:0001880) | 2.84467499 |
62 | Thyroiditis (HP:0100646) | 2.82528025 |
63 | Pancreatic fibrosis (HP:0100732) | 2.81687077 |
64 | Abnormality of the nasal mucosa (HP:0000433) | 2.80111368 |
65 | Hemoptysis (HP:0002105) | 2.80022486 |
66 | Cheilitis (HP:0100825) | 2.78737810 |
67 | Recurrent lower respiratory tract infections (HP:0002783) | 2.76095034 |
68 | Bronchitis (HP:0012387) | 2.74216801 |
69 | Lymphoma (HP:0002665) | 2.72473295 |
70 | True hermaphroditism (HP:0010459) | 2.71551637 |
71 | Osteomyelitis (HP:0002754) | 2.63809512 |
72 | Increased IgE level (HP:0003212) | 2.63478984 |
73 | Arterial thrombosis (HP:0004420) | 2.54758107 |
74 | Granulocytopenia (HP:0001913) | 2.53460042 |
75 | Abnormality of eosinophils (HP:0001879) | 2.51083151 |
76 | Leukocytosis (HP:0001974) | 2.50725960 |
77 | Joint swelling (HP:0001386) | 2.49064827 |
78 | Gastrointestinal infarctions (HP:0005244) | 2.48965956 |
79 | Keratoconjunctivitis sicca (HP:0001097) | 2.48150437 |
80 | Attenuation of retinal blood vessels (HP:0007843) | 2.43717002 |
81 | Thrombocytosis (HP:0001894) | 2.42581778 |
82 | Recurrent otitis media (HP:0000403) | 2.42518371 |
83 | Abnormality of the prostate (HP:0008775) | 2.41522926 |
84 | Nephronophthisis (HP:0000090) | 2.35996276 |
85 | Abnormality of the renal medulla (HP:0100957) | 2.33962405 |
86 | Increased IgM level (HP:0003496) | 2.33568823 |
87 | Restrictive lung disease (HP:0002091) | 2.33463641 |
88 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.32991069 |
89 | Spontaneous hematomas (HP:0007420) | 2.32930688 |
90 | Abnormality of macrophages (HP:0004311) | 2.31559986 |
91 | Keratoconjunctivitis (HP:0001096) | 2.29461769 |
92 | Leukopenia (HP:0001882) | 2.28620121 |
93 | Chronic hepatic failure (HP:0100626) | 2.28212289 |
94 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.26112769 |
95 | Stomach cancer (HP:0012126) | 2.23152329 |
96 | Autoimmune hemolytic anemia (HP:0001890) | 2.23016540 |
97 | Gingivitis (HP:0000230) | 2.20808436 |
98 | Periodontitis (HP:0000704) | 2.19384055 |
99 | Abolished electroretinogram (ERG) (HP:0000550) | 2.16637315 |
100 | Skin ulcer (HP:0200042) | 2.15797040 |
101 | Congenital, generalized hypertrichosis (HP:0004540) | 2.12287691 |
102 | Chest pain (HP:0100749) | 2.10851589 |
103 | Skin rash (HP:0000988) | 2.10840161 |
104 | Abnormal drinking behavior (HP:0030082) | 2.09942700 |
105 | Polydipsia (HP:0001959) | 2.09942700 |
106 | Arthralgia (HP:0002829) | 2.07775802 |
107 | Myocardial infarction (HP:0001658) | 2.07341763 |
108 | Hypergammaglobulinemia (HP:0010702) | 2.06458219 |
109 | Sepsis (HP:0100806) | 2.06406517 |
110 | Hyperventilation (HP:0002883) | 2.06228555 |
111 | Genetic anticipation (HP:0003743) | 2.03102821 |
112 | Renal cortical cysts (HP:0000803) | 2.02704544 |
113 | Large for gestational age (HP:0001520) | 1.98894069 |
114 | Cystic liver disease (HP:0006706) | 1.97897208 |
115 | Gingival bleeding (HP:0000225) | 1.97649729 |
116 | Type II lissencephaly (HP:0007260) | 1.97290302 |
117 | Hypochromic anemia (HP:0001931) | 1.97123435 |
118 | Interstitial pulmonary disease (HP:0006530) | 1.96640910 |
119 | Inability to walk (HP:0002540) | 1.92261508 |
120 | Bile duct proliferation (HP:0001408) | 1.91836679 |
121 | Abnormal biliary tract physiology (HP:0012439) | 1.91836679 |
122 | Progressive cerebellar ataxia (HP:0002073) | 1.91539379 |
123 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.91483075 |
124 | Tubular atrophy (HP:0000092) | 1.91442998 |
125 | Clumsiness (HP:0002312) | 1.90658852 |
126 | Progressive inability to walk (HP:0002505) | 1.90016677 |
127 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.87545881 |
128 | Pulmonary embolism (HP:0002204) | 1.87076570 |
129 | Abnormality of the pleura (HP:0002103) | 1.86740917 |
130 | Neutropenia (HP:0001875) | 1.85179289 |
131 | Hepatitis (HP:0012115) | 1.84431199 |
132 | Oligodactyly (hands) (HP:0001180) | 1.79714465 |
133 | Hypoplasia of the thymus (HP:0000778) | 1.79039197 |
134 | Pendular nystagmus (HP:0012043) | 1.78792498 |
135 | Gaze-evoked nystagmus (HP:0000640) | 1.77905226 |
136 | Bronchiectasis (HP:0002110) | 1.77864850 |
137 | Basal cell carcinoma (HP:0002671) | 1.77842469 |
138 | Concave nail (HP:0001598) | 1.77465388 |
139 | Decreased circulating renin level (HP:0003351) | 1.77304945 |
140 | Constricted visual fields (HP:0001133) | 1.75988836 |
141 | Polyuria (HP:0000103) | 1.75254604 |
142 | Fair hair (HP:0002286) | 1.74996530 |
143 | Furrowed tongue (HP:0000221) | 1.74176570 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 6.04695719 |
2 | FRK | 3.94197887 |
3 | TXK | 3.79781585 |
4 | MAP3K14 | 3.51220065 |
5 | JAK3 | 3.41434640 |
6 | TYK2 | 3.08672144 |
7 | ITK | 2.45557524 |
8 | FGFR4 | 2.41853074 |
9 | IKBKE | 2.38581768 |
10 | ZAP70 | 2.29292049 |
11 | TLK1 | 2.29207209 |
12 | JAK1 | 2.20351312 |
13 | IRAK4 | 2.06537761 |
14 | SYK | 2.05594112 |
15 | STK10 | 1.95103085 |
16 | BLK | 1.87666419 |
17 | IKBKB | 1.87486799 |
18 | MAP3K13 | 1.87227168 |
19 | SIK2 | 1.85874340 |
20 | FGFR3 | 1.85471819 |
21 | TBK1 | 1.85058642 |
22 | GRK6 | 1.83657377 |
23 | TEC | 1.81819328 |
24 | KIT | 1.81508485 |
25 | BTK | 1.78944580 |
26 | SIK3 | 1.74244847 |
27 | CAMKK2 | 1.73877133 |
28 | EEF2K | 1.70400502 |
29 | IRAK3 | 1.66365308 |
30 | LCK | 1.64631211 |
31 | ACVR1B | 1.63901218 |
32 | CSF1R | 1.63609350 |
33 | WNK4 | 1.62928160 |
34 | HCK | 1.61043847 |
35 | ZAK | 1.53485014 |
36 | BMPR1B | 1.51437559 |
37 | NLK | 1.51427259 |
38 | CSK | 1.46319727 |
39 | CHUK | 1.43153981 |
40 | MAP4K2 | 1.39987207 |
41 | CDK12 | 1.39175575 |
42 | EPHA3 | 1.32760674 |
43 | MAP2K6 | 1.31287250 |
44 | PRKCQ | 1.25062534 |
45 | MAPK13 | 1.23898198 |
46 | WNK3 | 1.23202642 |
47 | LYN | 1.20286704 |
48 | CLK1 | 1.16491894 |
49 | MAP3K10 | 1.11326294 |
50 | MARK3 | 1.10704386 |
51 | STK39 | 1.10702068 |
52 | EPHB1 | 1.09343214 |
53 | INSRR | 1.07928990 |
54 | MST4 | 1.07323461 |
55 | ERN1 | 1.06905076 |
56 | PIM1 | 1.06758044 |
57 | FES | 1.01014033 |
58 | OXSR1 | 0.98212608 |
59 | PRKCH | 0.98167579 |
60 | BRD4 | 0.94278129 |
61 | TGFBR1 | 0.91981299 |
62 | RIPK4 | 0.91262079 |
63 | SIK1 | 0.89171705 |
64 | CCNB1 | 0.83916762 |
65 | CAMKK1 | 0.82560385 |
66 | JAK2 | 0.81241034 |
67 | VRK1 | 0.81110235 |
68 | TAOK3 | 0.80749986 |
69 | LRRK2 | 0.79002114 |
70 | MAPK15 | 0.78967308 |
71 | DAPK2 | 0.78589290 |
72 | NME2 | 0.77608691 |
73 | ADRBK1 | 0.77573094 |
74 | STK24 | 0.74900597 |
75 | RPS6KA4 | 0.72812233 |
76 | TNK2 | 0.72502288 |
77 | STK11 | 0.70576200 |
78 | PINK1 | 0.68801020 |
79 | MAP3K7 | 0.67486485 |
80 | PIK3CG | 0.67225557 |
81 | IRAK1 | 0.61939222 |
82 | CDK4 | 0.58749735 |
83 | ALK | 0.57555994 |
84 | SGK3 | 0.57369761 |
85 | MAP3K4 | 0.56978059 |
86 | STK4 | 0.53552287 |
87 | PTK2B | 0.53253444 |
88 | TGFBR2 | 0.52357142 |
89 | GRK7 | 0.49644652 |
90 | MKNK2 | 0.49524223 |
91 | FGFR2 | 0.49251604 |
92 | MAP2K3 | 0.48898998 |
93 | TAOK2 | 0.47280922 |
94 | CDK19 | 0.46058524 |
95 | PRPF4B | 0.45836299 |
96 | CDK9 | 0.45748049 |
97 | HIPK2 | 0.45583488 |
98 | CAMK4 | 0.44139587 |
99 | ABL1 | 0.42910487 |
100 | RPS6KA6 | 0.42514054 |
101 | EGFR | 0.42496698 |
102 | SGK2 | 0.42281290 |
103 | KDR | 0.41428763 |
104 | MAPK7 | 0.40858903 |
105 | MAPK12 | 0.40756949 |
106 | TSSK6 | 0.40524671 |
107 | UHMK1 | 0.39947795 |
108 | PIM2 | 0.39738858 |
109 | NUAK1 | 0.38880948 |
110 | ATR | 0.37876178 |
111 | MAPKAPK3 | 0.37681490 |
112 | MAPK11 | 0.37107763 |
113 | INSR | 0.36694958 |
114 | TAOK1 | 0.35522141 |
115 | BMPR2 | 0.35521756 |
116 | TYRO3 | 0.35344272 |
117 | NEK9 | 0.34987609 |
118 | PAK3 | 0.34019887 |
119 | EIF2AK3 | 0.33923013 |
120 | EIF2AK2 | 0.33627050 |
121 | NTRK2 | 0.33555867 |
122 | IGF1R | 0.33261021 |
123 | MAP3K11 | 0.32284032 |
124 | DYRK2 | 0.32260048 |
125 | TNIK | 0.32254558 |
126 | PTK6 | 0.31810633 |
127 | PASK | 0.30811466 |
128 | PDK1 | 0.30487253 |
129 | MAPKAPK2 | 0.29491063 |
130 | MELK | 0.29246823 |
131 | NEK2 | 0.29065572 |
132 | CAMK1 | 0.28917170 |
133 | MAPK3 | 0.28250414 |
134 | CDK6 | 0.27302056 |
135 | RPS6KA5 | 0.26691070 |
136 | FYN | 0.26350866 |
137 | FLT3 | 0.25221254 |
138 | MAP3K8 | 0.24958584 |
139 | MARK2 | 0.24590127 |
140 | PRKCD | 0.23870262 |
141 | GRK1 | 0.23121471 |
142 | PDGFRB | 0.22587899 |
143 | PKN2 | 0.21809029 |
144 | ADRBK2 | 0.21630915 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.44333433 |
2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.27218650 |
3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.26373055 |
4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.17754709 |
5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.99746040 |
6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.81885972 |
7 | Measles_Homo sapiens_hsa05162 | 2.76408742 |
8 | Allograft rejection_Homo sapiens_hsa05330 | 2.48314588 |
9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.38286862 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.23284558 |
11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.22279055 |
12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.21574677 |
13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.21384088 |
14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.19219590 |
15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.92843464 |
16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.90926910 |
17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.90584526 |
18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.85512432 |
19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.84708728 |
20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.81462471 |
21 | Phototransduction_Homo sapiens_hsa04744 | 1.80790249 |
22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.73287340 |
23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.66360008 |
24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55138304 |
25 | Influenza A_Homo sapiens_hsa05164 | 1.54024610 |
26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45703323 |
27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45036745 |
28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.40445957 |
29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36246147 |
30 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.36045275 |
31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.34461361 |
32 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.33669135 |
33 | Hepatitis B_Homo sapiens_hsa05161 | 1.32217851 |
34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29489863 |
35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28782374 |
36 | Tuberculosis_Homo sapiens_hsa05152 | 1.27284043 |
37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.26944129 |
38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26752133 |
39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.20811146 |
40 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.20574372 |
41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19951256 |
42 | Apoptosis_Homo sapiens_hsa04210 | 1.17150754 |
43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.15244313 |
44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.15126563 |
45 | Legionellosis_Homo sapiens_hsa05134 | 1.13322081 |
46 | Shigellosis_Homo sapiens_hsa05131 | 1.06241109 |
47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.05985775 |
48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05882536 |
49 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.03994116 |
50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03880416 |
51 | Asthma_Homo sapiens_hsa05310 | 1.03369506 |
52 | Hepatitis C_Homo sapiens_hsa05160 | 1.03093887 |
53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.00036103 |
54 | Malaria_Homo sapiens_hsa05144 | 0.98261285 |
55 | Pertussis_Homo sapiens_hsa05133 | 0.97918257 |
56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.94478399 |
57 | RNA polymerase_Homo sapiens_hsa03020 | 0.94259584 |
58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94067558 |
59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93674748 |
60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.92312414 |
61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90814352 |
62 | Base excision repair_Homo sapiens_hsa03410 | 0.89468262 |
63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89283041 |
64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.87555838 |
65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82752357 |
66 | Ribosome_Homo sapiens_hsa03010 | 0.79510749 |
67 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.78979428 |
68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.77551527 |
69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.74638891 |
70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73914369 |
71 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.71533257 |
72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70694275 |
73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69812686 |
74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68165813 |
75 | Basal transcription factors_Homo sapiens_hsa03022 | 0.67663685 |
76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66677037 |
77 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.65981988 |
78 | Morphine addiction_Homo sapiens_hsa05032 | 0.65334109 |
79 | Salmonella infection_Homo sapiens_hsa05132 | 0.63699849 |
80 | Taste transduction_Homo sapiens_hsa04742 | 0.63036443 |
81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62496073 |
82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62410573 |
83 | Nicotine addiction_Homo sapiens_hsa05033 | 0.59042506 |
84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58884093 |
85 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57343715 |
86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57262929 |
87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57250309 |
88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57113650 |
89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56487047 |
90 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56147051 |
91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55631284 |
92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55414812 |
93 | DNA replication_Homo sapiens_hsa03030 | 0.52078355 |
94 | Platelet activation_Homo sapiens_hsa04611 | 0.51790745 |
95 | Parkinsons disease_Homo sapiens_hsa05012 | 0.51608060 |
96 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51489175 |
97 | Mismatch repair_Homo sapiens_hsa03430 | 0.51444555 |
98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50663435 |
99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50338703 |
100 | Protein export_Homo sapiens_hsa03060 | 0.49606758 |
101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48227375 |
102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47410766 |
103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46742266 |
104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45432314 |
105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44457890 |
106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43443940 |
107 | Homologous recombination_Homo sapiens_hsa03440 | 0.42006863 |
108 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41856739 |
109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41080559 |
110 | Lysine degradation_Homo sapiens_hsa00310 | 0.40542817 |
111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40313516 |
112 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40177325 |
113 | Spliceosome_Homo sapiens_hsa03040 | 0.39574718 |
114 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.39359762 |
115 | RNA degradation_Homo sapiens_hsa03018 | 0.39007337 |
116 | Prostate cancer_Homo sapiens_hsa05215 | 0.38321683 |
117 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.37574083 |
118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37392850 |
119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36999812 |
120 | Other glycan degradation_Homo sapiens_hsa00511 | 0.35052136 |
121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33408183 |
122 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.32923380 |
123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32093077 |
124 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.31736913 |
125 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30141791 |
126 | Peroxisome_Homo sapiens_hsa04146 | 0.30005034 |
127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29019502 |
128 | ABC transporters_Homo sapiens_hsa02010 | 0.27976310 |
129 | Insulin resistance_Homo sapiens_hsa04931 | 0.27267187 |
130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24644375 |
131 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.24454384 |
132 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22588609 |
133 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21890420 |
134 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.21479799 |
135 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21412780 |
136 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.21310323 |
137 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.20989575 |
138 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.20493078 |
139 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.20248999 |
140 | Endocytosis_Homo sapiens_hsa04144 | 0.19549896 |
141 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.19355852 |
142 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.18177052 |
143 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.18057841 |
144 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.16960599 |
145 | Huntingtons disease_Homo sapiens_hsa05016 | 0.16602244 |
146 | Pathways in cancer_Homo sapiens_hsa05200 | 0.16599097 |
147 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.15386120 |